series-a+, Growth
$10.0M – $30.0M
$180M
7+ companies
8 partners
Investment Thesis
Focuses exclusively on longevity startups developing next-generation therapies to extend healthspan and address aging-related diseases.
Meet the Team
Industry Focus
Invests In
Portfolio Companies (7)
Other
Cleara Biotech
Rejuvenate Biomed
Auron
"Discovered via firm_website (high confidence)"
Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies
Therini Bio
"Discovered via firm_website (high confidence)"
Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
HAYA Therapeutics
"Discovered via firm_website (high confidence)"
Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
Auron Therapeutics
"Discovered via firm_website (high confidence)"
Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia
Booster Therapeutics
"Discovered via firm_website (high confidence)"
Launches with $15 M seed financing led by Apollo Health Ventures and Novo Holdings
Browse More Investors
Frequently Asked Questions
See if Apollo Health Ventures is a match for your startup
Upload your pitch deck to see how well you match with Apollo Health Ventures and 200+ other VC firms.